mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |